Chronic heart failure

Find all the latest content on chronic heart failure published on this website.

A complex condition, long-term management of chronic heart failure demands an understanding of the underlying causes and symptoms as well as the skills and knowledge to provide an effective treatment that can offer quality of life for the patient. To do this, acquaintance with the latest tools, assist devices and techniques, various biosensors or biomarkers and the different imaging modalities available is essential. These, along with subjects such as adjunctive pharmacotherapy, vascular access or bleeding risks, can be found here…

Filtered By
Chronic heart failure

70 results

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

PCRonline @ ACC.25 Scientific Sessions

07 Feb 2025

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25

PCRonline @ ACC.25 Scientific Sessions

Mechanical circulatory support: role in the management of high-risk PCI and AMI-cardiogenic shock

19 Dec 2024 – From GulfPCR-GIM 2024

This session highlights the essential role of mechanical circulatory support (MCS) in managing high-risk PCI and AMI-related cardiogenic shock. Explore case-based discussions on device selection, hemodynamic impact, and evidence-based strategies to optimize outcomes in complex scenarios.

Mechanical circulatory support: role in the management of high-risk PCI and AMI-cardiogenic shock

AHA 2024: get the interventional cardiology perspective!

13 Nov 2024

Stay up to date with what is new and hot in interventional cardiology at #AHA24 in Chicago.

PCRonline @ AHA 2024

Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis (TAVR UNLOAD)

28 Oct 2024

Mirvat Alasnag interviews Nicolas M. Van Mieghem about the results of the TAVR UNLOAD trial he presented at the TCT Conference 2024.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
N. Van Mieghem

Author

Nicolas Van Mieghem
Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis (TAVR UNLOAD)

PCR @ TCT 2024 - Get the international perspective!

11 Oct 2024

Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2024 - check out the list below.

PCRonline @ TCT 2024 - get the international perspective!

Cutting-edge research in interventional cardiology: from coronary stenosis assessment to valve regurgitation treatment

05 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in the latest advancements and insights from the AICT-AsiaPCR 2024 Abstract submissions. This captivating session covers a diverse range of topics, from the cost-effectiveness of functional syntax score versus anatomical syntax score in treatment strategy, to the temporal trends in left main bifurcation PCI....

Cutting-edge research in interventional cardiology: from coronary stenosis assessment to valve regurgitation treatment

Structural cardiac interventions in patients with heart failure

27 Aug 2024

The review aims to address the unmet needs in heart failure (HF) management, particularly in patients where structural heart disease coexists with HF and limits the effectiveness of guideline-directed medical therapy (GDMT).

Alessandro Sticchi

Reviewer

Alessandro Sticchi
Structural cardiac interventions in patients with heart failure

MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

01 Sep 2024

Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

Yohei Ohno

Author

Yohei Ohno
MATTERHORN

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2